FluoroPharma Medical, Inc. (FPMI)

Market Cap	2.76K
Revenue (ttm)	n/a
Net Income (ttm)	-2.57M
Shares Out	27.58M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	5
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.0001 - 0.0001
Beta	-87.24
RSI	35.31
Earnings Date	n/a

About FluoroPharma Medical

FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. Its product candidates include BFPET, an imaging agent that has completed a Phase I clinical trial in stress-testing for patients with presumptive or proven coronary artery disease (CAD); and CardioPET, a molecular imaging agent, which is in Phase IIa clinical trial to assess myocardial blood flow and metabolism in pati...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2003
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: FPMI